Thursday, October 15, 2026
Via News Knowledge File

OpenAI

organization100% conf.·synced Oct 15, 2026

AI company seeking $800 billion valuation, maker of ChatGPT

59
sourced metrics
2413
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Capital Expenditure Previous Estimate
1400USD
Dec 31, 2030source
Capital Expenditure Target
600USD
Dec 31, 2030source
Acquisition Count
20acquisitions
Sep 29, 2026source
Agents Used
10000agents
Sep 9, 2026source
Time To Solve
88hours
Sep 9, 2026source
Acquisition Count This Year
8companies
Aug 24, 2026source
Cumulative Acquisition Count
19companies
Aug 24, 2026source
Conversations Analyzed
1500000count
Aug 18, 2026source
Work Related Use Share
30percent
Aug 18, 2026source
Agent Security Tooling Usage Rate
26percent
Jul 16, 2026source
Purchase Consideration Rate
34percent
Jul 16, 2026source
Switching Consideration Share
30percent
Jul 16, 2026source
Market Share
13percent
Jul 15, 2026source
Cash Burn Rate
3billion_USD_per_month
Jul 12, 2026source
Market Cap
1000USD
Jul 5, 2026source
Proposed Government Ownership Stake
5percent
Jul 2, 2026source
Deepmind Hires Count
3employees
Jul 2, 2026source
Net Income
-140USD
May 25, 2026source

Stated objectives

Raise at least $50 billion in new investment round

source
target: 50 billion_USDby 2026-03-01 00:00:00stated

Spend more than $1.4 trillion on AI infrastructure in the coming years

source
target: 1400 billion_USDby 2030-12-31 00:00:00stated

Build $100 billion UAE-based data center under Stargate initiative

source
target: 100 billion_USDstated

Implement advertising model to support $1.5 trillion spending plans

source
target: 1.5 trillion USD stated

Launch AI hardware collaboration with Jony Ive

source
by 2026-01-01 00:00:00stated

OpenAI 10 gigawatt capacity deployment

source
target: 10 gigawatts by 2029-12-31 00:00:00stated

Complete IPO and become publicly traded

source
by 2026-01-01 00:00:00stated

Raise additional capital

source
target: as much as 100 billion USD by 2026-03-31 00:00:00stated

Go public through IPO to raise capital

source
target: 1000000000000 stated

Revenue growth projection to close $207 billion funding gap by 2030

source
target: Close funding gap by 2030-01-01 00:00:00stated

Relationship graph · 2413 connections

Competes with
565
Developed by
458
Employs
256
Customer of
229
Invested in
216
Supplies to
154
contracted by
57
founded
44

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com